CDC still recommends childhood COVID vaccines, despite RFK announcement
CDC still recommends childhood COVID vaccines, despite RFK announcement The Covid-19 vaccine remains on the CDC's revised schedule of childhood vaccinations.
Show Caption
Hide Caption
RFK Jr. says COVID-19 vaccine no longer recommended for some
The COVID-19 vaccine is no longer recommended for healthy children and pregnant women, HHS Secretary Robert F. Kennedy Jr. says.
Health Secretary Robert F. Kennedy Jr. announced recently the government would stop recommending routine Covid vaccinations.
'The CDC and HHS encourage individuals to talk with their healthcare provider on any medical decisions,' a Kennedy spokesman told the Washington Post.
WASHINGTON −The Centers for Disease Control and Prevention is still recommending COVID vaccines for healthy children, the Washington Post reported May 30, citing the CDC's latest published immunization schedule.
The schedule, published late on May 29 by the public health agency, comes after Health and Human Services Secretary Robert F. Kennedy Jr − alongside the heads of the FDA and the NIH − earlier this week said the U.S. would stop recommending routine COVID-19 vaccines for healthy children and pregnant women.
More: White House blames 'formatting' for errors in RFK Jr.'s MAHA report. Authors push back.
The new guidance says that parents who want to vaccinate a child for the coronavirus "may receive COVID-19 vaccination, informed by the clinical judgment of a healthcare provider and personal preference and circumstances."
Kennedy Jr., FDA commissioner Marty Makary and NIH director Jay Bhattacharya had said in a video that the shots were removed from the CDC's recommended immunization schedule.
The CDC, following its panel of outside experts, previously recommended updated COVID vaccines for everyone aged six months and older, and current recommendations are in line with those made before.
'The CDC and HHS encourage individuals to talk with their healthcare provider on any medical decisions,' HHS spokesman Andrew Nixon said in an email to the Post.
"If a parent desires their healthy child to be vaccinated or if a pregnant woman desires to be vaccinated, their decision should be based on informed consent through the clinical judgment of their healthcare provider,' Nixon said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
an hour ago
- Forbes
Subtle Differences Emerge Between FDA And CDC On COVID Vaccine Advice
An illustration picture shows vials with Covid-19 vaccine stickers attached and syringes with the ... More logo of the company Novavax. (Photo by JUSTIN TALLIS / AFP) (Photo by JUSTIN TALLIS/AFP via Getty Images) In a major policy shift last month, Food and Drug Administration officials proposed requiring new clinical trial research with respect to the effectiveness of COVID-19 vaccines in healthy people under 65, including pregnant women, before issuing an updated approval for a broader population. At the same time, in an update to its immunization schedule posted May 29th, the Centers for Disease Control and Prevention include the option of COVID-19 vaccines for healthy children and pregnant women. Based on the language used by CDC, it suggests the agency aims for a shared decision-making approach in which individuals consult with their doctor prior to getting a shot. We witnessed a preview of the new FDA approach when the agency made an unusual decision to limit the approval of the nation's only non-mRNA coronavirus vaccine, Novavax's nuvaxovid, for use only in adults 65 and older or those 12 to 64 who have at least one health problem that puts them at increased risk from COVID-19. To be indicated for a broader population, the FDA plans to require that vaccine makers conduct booster trials to demonstrate effectiveness in people under 65 or without certain risks. These trials could take a year to complete, according to a STAT report. As such, it's not something that can be accomplished prior to the autumn, even if Novavax, Pfizer, or Moderna, wished to pursue this pathway. Similar to annual flu shots, which adapt to new strains, COVID-19 boosters update immunity to target evolving variants. Data from several years of booster campaigns show lower hospitalization and death rates for boosted individuals compared to unvaccinated people or those who haven't gotten boosters. This particularly applies to the vulnerable subpopulations, stratified by age and underlying health conditions. The COVID-19 vaccines, both mRNA and non-mRNA, are recommended for anyone who is over 65 or who has a medical condition that can increase the risk of severe illness or death. Underlying conditions include, among other things, obesity, 'physical inactivity,' diabetes, clinical depression and being immunocompromised. It's estimated that between 100 and 200 million Americans will still be eligible for vaccination due to having such health issues. Nevertheless, this raises questions for people who don't have underlying health conditions and are under 65 but would like to get a COVID-19 shot this fall. The FDA and CDC appear to differ subtly in terms of their current advice for healthy individuals under 65. Is it possible for these folks to obtain a jab at the pharmacy with no questions asked? Or will they have to go to their doctor and be granted de facto permission to get the shot? Perhaps equally important, will their insurer pay for it? As the New York Times explains, insurance companies may serve as the 'gatekeepers by demanding medical documentation of an underlying condition before agreeing to cover the cost.' The out-of-pocket cost to patients could be as much $140 a shot. Top FDA officials Prasad and Makary advocate an 'evidence-based' approach to COVID-19 vaccination. They also write of aligning policy with Europe. Indeed, in most instances, European public health authorities have adopted a targeted approach that aims at ensuring the elderly and those with underlying health conditions get boosted. This means that outreach campaigns in European countries only target subpopulations for which the vaccine is recommended by the respective public health authority. This is unlike the universal recommendations previously issued by the CDC that didn't differentiate by age or risk factors. However, the European agencies in charge of vaccine approval, the EMA and MHRA, haven't suggested marketing authorization changes, such as narrowing the indication based on age, for any of the approved COVID-19 vaccines.
Forbes
2 hours ago
- Forbes
The Benefits And Drawbacks Of RFK Jr.'s New COVID Vaccine Recommendations
SAVANNAH, GA - DECEMBER 15: A nurse shows off a vial of the Pfizer-BioNTech COVID-19 vaccine ... More outside of the Chatham County Health Department on December 15, 2020 in Savannah, Georgia. (Photo by) RFK Jr. and the HHS will no longer recommend annual COVID-19 vaccines for healthy pregnant women and young adults, according to a video announcement posted on X May 27 by Secretary of Health and Human Services Robert F. Kennedy Jr. A few days later, the CDC took a slightly different stance and stated that children between the ages of 6 months and 17 years may get the COVID-19 vaccine through shared decision-making between parents and healthcare providers. The CDC also updated the adult immunization schedule to say there is 'no guidance' on use for pregnancy. These decisions have sparked much debate among public health experts, policymakers and government officials. Here are the pros and cons of such a policy shift. As Kennedy cited in his video announcement, the U.S. seems to be aligning its vaccine policy with other countries such as the U.K. and Australia that have stopped recommending routine COVID-19 vaccines for young healthy adults. In addition, according to the new recommendations, the focus of vaccinations will largely be on high-risk populations, namely those who are 65 years of age and older as well as younger individuals with at least one medical condition that puts them at high risk for COVID-19. This could allow resources and attention to be redirected to the populations that need the vaccine most. The new recommendations also demand evidence in answering important questions the public deserves to know. For younger healthy American adults, getting approval for the vaccine will require placebo-controlled trials to show a benefit for that particular population. As an example, does a healthy 31-year-old male with no medical problems need to get a COVID-19 booster every single year, even after having received several COVID-19 boosters in the past? These are the types of questions that all Americans would like to and deserve to know with respect to COVID vaccinations. On the flip side, the new recommendations have many public health experts concerned. Pregnant healthy females could be barred from getting the COVID-19 vaccine, since the CDC has failed to provide guidance on the issue. Without a strong recommendation from the CDC, many pregnant patients could face real barriers from insurance companies to cover the vaccine, according to The New York Times. Pregnant women are at high risk for COVID infection and complications because pregnancy results in a weakened immune system. As Dr. Steven Fleischman, President of the American College of Obstetricians and Gynecologists states, 'The science has not changed. It is very clear that COVID infection during pregnancy can be catastrophic and lead to major disability.' The new recommendations could harm vulnerable populations. In addition to potential decreased vaccination rates and adverse outcomes for pregnant females, children could also suffer. When pregnant females get vaccinated against COVID-19 in the third trimester, they are able to pass along antibodies and protection to their infants, who have not developed mature immune systems. If pregnant females do not get vaccinated, infants will lack these antibodies and could then go on to develop severe complications from the virus should they get infected. Finally, the new recommendations could limit access to the vaccine to those that want it. Private insurance companies usually require FDA approval and CDC recommendations to cover the vaccine as part of health insurance. The current CDC recommendations simply state young children may get the vaccine with shared-decision making, not outright stating that they should get the vaccine. In addition, the CDC falls short in explicitly recommending the vaccine for pregnant females. This could prevent private insurance companies from fully covering the vaccine. Ultimately, this may mean some pregnant women and those that cannot afford the vaccine may not have access to it. The new recommendations for the COVID-19 vaccine for children and pregnant females was made without the customary use of independent advisors, and could have important implications for public health. While aligning with international practices, the move could significantly limit the amount of vaccines available for millions of Americans.
CNET
2 hours ago
- CNET
Will I Have to Pay for a COVID Vaccine and How Much Will It Cost?
Under the direction of Health and Human Services Secretary Robert F. Kennedy Jr., government policies surrounding the COVID-19 vaccine have changed dramatically, casting new doubts on its availability and cost in the coming months. This past week, Kennedy announced that the Centers for Disease Control and Prevention was pulling its recommendation for routine COVID booster shots for "healthy" pregnant women and children. This came not long after the agency also pulled the recommendation for any adults younger than 65 without at least one condition that puts them at high-risk for a more severe infection. How the government defines "healthy" in this context is still unclear. Notably, pregnancy is considered a high-risk condition in and of itself. Other conditions currently include asthma, cancer and diabetes. The CDC later contradicted Kennedy's announcement, stating that healthy children, ages 6 months to 17 years old, can get COVID shots after receiving "the clinical judgment of a health-care provider." Set against the broader concern about Kennedy's history of anti-vaccine beliefs, these moves have caused renewed concern about the ability of Americans who want them to get COVID boosters, especially ahead of fall and winter when infection rates are known to increase. According to data from the CDC itself, about 70% of Americans were considered fully vaccinated against COVID as of May 2023. These boosters are still desirable for many Americans, however, particularly for those who might be considered healthy themselves but live with high-risk friends or family. Putting barriers in the way of COVID vaccination could also increase the risks of variant strains developing and spreading among more individuals. If you're concerned or intrigued about what these moves against vaccine recommendations might mean for you, keep reading. For more, find out what Novavax might mean for the cost of COVID-19 vaccines. What does ending COVID vaccine recommendations mean? Hearing that the government has ended certain vaccine "recommendations" might seem a little vague but there are a few important ramifications to keep in mind. For starters, ending the recommendation for a vaccine would remove it from the required immunization schedule for children, although the CDC's contradiction of Kennedy's initial announcement has muddied things on this count. For the time being, it seems that the ability of kids to get updated COVID shots is nominally safe. More pressingly for most healthy adults who might want to get regular booster shots, government recommendations are typically used by health insurance companies to decide which shots they will cover and for whom. So in effect, you might still be able to seek out a booster shot for yourself or your child, but now it could cost you. How much will a COVID-19 booster shot cost? It's hard to say for certain how every individual insurance company will react to these decisions from the CDC but should your provider choose to end coverage for booster shots, you'll have to pay to get one. As for how much that will cost you, that's another thing we can't know for sure right now, but you should expect it to be in the ballpark of a couple hundred dollars. According to CVS's webpage, the pharmacy chain charges at least $199 for a COVID vaccine shot that is not covered by insurance. For the time being, the company says they are free of charge with insurance. For more info about staying safe, find out how to check if your at-home COVID tests are expired.
